⌘K

Home/Filings/4/0001048477-25-000041

4//SEC Filing

Burkhart Erin 4

Accession 0001048477-25-000041

CIK 0001048477other

View on SEC.gov Company Profile

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 7:38 PM ET

Size

4.8 KB

Accession

0001048477-25-000041

Insider Transaction Report

Form 4

Period: 2025-03-19

BIOMARIN PHARMACEUTICAL INCBMRN

GVP, Chief Accounting Officer

Transactions

Sale
Common Stock
2025-03-19$71.52/sh−1,295$92,618→ 16,955 total

Footnotes (2)

[F1]Trade made pursuant to a 10b5-1 plan executed on November 26, 2024.
[F2]The Reporting Person's direct holdings have been adjusted by two shares to correct a previous clerical error.

Documents

1 file

4
wk-form4_1742513921.xmlPrimary
FORM 4

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1

filerCIK 0001927648

Filing Metadata

Form type: 4
Filed: Mar 19, 8:00 PM ET
Accepted: Mar 20, 7:38 PM ET
Size: 4.8 KB

View on SEC.gov